Renovaro Inc. Faces Delisting Notice
Ticker: LNAI · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1527728
| Field | Detail |
|---|---|
| Company | Renovaro Inc. (LNAI) |
| Form Type | 8-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, company-name-change
TL;DR
Renovaro Inc. got a notice about potentially being delisted.
AI Summary
Renovaro Inc. filed an 8-K on July 14, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as Enochian Biosciences Inc. and Renovaro Biosciences Inc., is incorporated in Delaware and its fiscal year ends on June 30.
Why It Matters
This filing indicates potential issues with Renovaro Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- Renovaro Inc. (company) — Registrant
- July 14, 2025 (date) — Date of earliest event reported
- Enochian Biosciences Inc. (company) — Former company name
- Renovaro Biosciences Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the specific reason for the notice of delisting or failure to satisfy a continued listing rule?
The provided text states that the filing is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing' but does not specify the exact rule or standard that was not met.
When was the company formerly known as Enochian Biosciences Inc.?
The company was formerly known as Enochian Biosciences Inc. until a name change on August 4, 2023.
What is Renovaro Inc.'s Standard Industrial Classification (SIC) code?
Renovaro Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Renovaro Inc. headquartered?
Renovaro Inc.'s business and mailing address is Century City Medical Plaza, 2080 Century City East, Suite 906, Los Angeles, CA 90067.
What is the Commission File Number for Renovaro Inc.?
The Commission File Number for Renovaro Inc. is 001-38751.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding RENOVARO INC. (LNAI).